Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 1;14(6):1953-1957.
doi: 10.14336/AD.2023.0502.

Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium

Dechao Feng  1 , Dengxiong Li  1 , Ruicheng Wu  1 , Ping Han  1
Affiliations

Scientific Advancements in Drug Development and Trials for Urothelial Carcinoma: Insights From the 2023 ASCO-GU Cancers Symposium

Dechao Feng et al. Aging Dis. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Novel agents and trials for UC. (A) word cloud showing medication clusters; (B) word cloud showing specific treatments; (C) word cloud showing patient types; (D) summary of novel agents and trials for UC in this meeting. UC: urothelial carcinoma; MIBC: muscle-invasive bladder cancer; BCG: Bacillus Calmette Guérin; EV: enfortumab vedotin; la/mUC: locally advanced or metastatic UC; SG: Sacituzumab govitecan PCT: platinum-based chemotherapy; ORR: objective response rate; MIUC: muscle-invasive urothelial carcinoma; PFS: progression-free survival; OS: overall survival; HR: high-risk. QoL: quality of life; HRQoL: health-related QoL.
See this image and copyright information in PMC

References

    1. Shen W, He J, Hou T, Si J, Chen S (2022). Common Pathogenetic Mechanisms Underlying Aging and Tumor and Means of Interventions. Aging Dis, 13:1063-91. - PMC - PubMed
    1. Feng D, Bai Y, Liu S, Yang Y, Han P, Wei W (2021). Risk of renal cancer in patients with inflammatory bowel disease: A pooled analysis of population-based studies. Urol Oncol, 39:93-9. - PubMed
    1. Feng D, Li D, Shi X, et al. (2022). A gene prognostic index from cellular senescence predicting metastasis and radioresistance for prostate cancer. J Transl Med, 20:252. - PMC - PubMed
    1. Feng D, Shi X, You J, Wei Q, et al. (2022). A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer. Am J Cancer Res, 12:3811-28. - PMC - PubMed
    1. Feng D, Shi X, Zhang F, Xiong Q, Wei Q, Yang L (2022). Energy Metabolism-Related Gene Prognostic Index Predicts Biochemical Recurrence for Patients With Prostate Cancer Undergoing Radical Prostatectomy. Front Immunol, 13:839362. - PMC - PubMed

LinkOut - more resources